##  [Novartis receives FDA approval for inclusion of new evidence that Cosentyx® inhibits progression of joint structural damage in psoriatic arthritis](/us-en/news/media-releases/novartis-receives-fda-approval-inclusion-new-evidence-cosentyx-inhibits-progression-joint-structural-damage-psoriatic-arthritis-0 "Novartis receives FDA approval for inclusion of new evidence that Cosentyx® inhibits progression of joint structural damage in psoriatic arthritis") 

  Jun 19, 2018